Insider Trading Alert - CRDC, IBTX And ELLI Traded By Insiders

Friday, Feb. 19, 2016, 80 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $162.00 to $7,446,158.70.

Highlighted Stocks Traded by Insiders:

Cardica (CRDC) - FREE Research Report

Bates Michael A., who is Director at Cardica, bought 1,000 shares at $2.53 on Feb. 19, 2016. Following this transaction, the Director owned 21,000 shares meaning that the stake was boosted by 5% with the 1,000-share transaction.

The shares most recently traded at $2.63, up $0.10, or 3.8% since the insider transaction. Historical insider transactions for Cardica go as follows:

  • 4-Week # shares bought: 75,000
  • 12-Week # shares bought: 75,000
  • 24-Week # shares bought: 75,000

The average volume for Cardica has been 75,100 shares per day over the past 30 days. Cardica has a market cap of $21.9 million and is part of the health care sector and health services industry. Shares are up 59.43% year-to-date as of the close of trading on Friday.

Cardica, Inc. designs, manufactures, and markets automated anastomotic systems for use by cardiac surgeons to perform coronary bypass surgery in the United States and internationally. Currently, there is 1 analyst who rates Cardica a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRDC - FREE

TheStreet Quant Ratings rates Cardica as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Cardica Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Independent Bank Group (IBTX) - FREE Research Report

Hickox Michelle S, who is EVP and CFO at Independent Bank Group, bought 250 shares at $27.50 on Feb. 19, 2016. Following this transaction, the EVP and CFO owned 19,145 shares meaning that the stake was boosted by 1.32% with the 250-share transaction.

The shares most recently traded at $27.15, down $0.35, or 1.29% since the insider transaction. Historical insider transactions for Independent Bank Group go as follows:

  • 4-Week # shares bought: 540
  • 4-Week # shares sold: 4,000
  • 12-Week # shares bought: 3,460
  • 12-Week # shares sold: 8,000
  • 24-Week # shares bought: 4,150
  • 24-Week # shares sold: 4,000

The average volume for Independent Bank Group has been 68,400 shares per day over the past 30 days. Independent Bank Group has a market cap of $458.0 million and is part of the financial sector and banking industry. Shares are down 14.94% year-to-date as of the close of trading on Friday.

Independent Bank Group, Inc. operates as a bank holding company for Independent Bank that provides commercial banking products and services for businesses, professionals, and individuals in the United States. The stock currently has a dividend yield of 1.2%. The company has a P/E ratio of 12.1. Currently, there are no analysts who rate Independent Bank Group a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IBTX - FREE

TheStreet Quant Ratings rates Independent Bank Group as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. Get the full Independent Bank Group Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Ellie Mae (ELLI) - FREE Research Report

Buccellato Carl, who is Director at Ellie Mae, sold 10,000 shares at $75.08 on Feb. 19, 2016. Following this transaction, the Director owned 28,953 shares meaning that the stake was reduced by 25.67% with the 10,000-share transaction.

Hu Limin, who is Evp, Cto at Ellie Mae, sold 3,368 shares at $77.61 on Feb. 19, 2016. Following this transaction, the Evp, Cto owned 233,016 shares meaning that the stake was reduced by 1.42% with the 3,368-share transaction.

Luce Edgar, who is Chief Financial Officer at Ellie Mae, sold 3,962 shares at $75.71 on Feb. 19, 2016. Following this transaction, the Chief Financial Officer owned 66,991 shares meaning that the stake was reduced by 5.58% with the 3,962-share transaction.

Tyrrell Joseph P., who is EVP, Corporate Strategy at Ellie Mae, sold 1,205 shares at $77.70 on Feb. 19, 2016. Following this transaction, the EVP, Corporate Strategy owned 27,100 shares meaning that the stake was reduced by 4.26% with the 1,205-share transaction.

The shares most recently traded at $84.64, up $6.94, or 8.2% since the insider transaction. Historical insider transactions for Ellie Mae go as follows:

  • 4-Week # shares bought: 1,005
  • 4-Week # shares sold: 16,362
  • 12-Week # shares bought: 1,005
  • 12-Week # shares sold: 27,362
  • 24-Week # shares bought: 1,005
  • 24-Week # shares sold: 29,512

The average volume for Ellie Mae has been 718,300 shares per day over the past 30 days. Ellie Mae has a market cap of $2.4 billion and is part of the technology sector and computer software & services industry. Shares are up 35.78% year-to-date as of the close of trading on Friday.

Ellie Mae, Inc. provides on-demand software solutions and services for the residential mortgage industry in the United States. Its mortgage management solution offers a system of record that allows banks, credit unions, and mortgage lenders to originate and fund mortgages. The company has a P/E ratio of 109.7. Currently, there are 4 analysts who rate Ellie Mae a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ELLI - FREE

TheStreet Quant Ratings rates Ellie Mae as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and good cash flow from operations. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Ellie Mae Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Stocks Lower as Wall Street Grapples With Growth Concerns

Stocks Lower as Wall Street Grapples With Growth Concerns

Jack in the Box Rises as Company Explores Sale

Jack in the Box Rises as Company Explores Sale

Changing My Trading Plan on IWM

Changing My Trading Plan on IWM

At This Point There Is Nothing to Suggest That the Corrective Action Is Over

At This Point There Is Nothing to Suggest That the Corrective Action Is Over

Texas Fund's Soured Bet on Exotic-Country Stocks Takes Further Hit

Texas Fund's Soured Bet on Exotic-Country Stocks Takes Further Hit